» Articles » PMID: 39132343

Management of Peripheral Arterial Disease: Lifestyle Modifications and Medical Therapies

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Peripheral artery disease (PAD) commonly refers to atherosclerotic narrowing of noncoronary arteries, primarily those supplying the lower extremities. The risk factors for PAD include smoking, hyperlipidemia, hypertension, and diabetes mellitus. Patients with PAD are at a heightened risk of major adverse cardiovascular events (including myocardial infarction, stroke, and cardiovascular death) and major adverse limb events (including progressive symptoms or limb ischemia requiring peripheral revascularization, amputation, and acute limb ischemia), highlighting the need for guideline-directed therapies. Lifestyle modifications and medical therapies are utilized to improve function and outcomes in this patient population. Adherence to a healthy diet and smoking cessation are both associated with better outcomes in patients with PAD. Medical therapies targeting axes of risk, including lipid-modifying therapies, antithrombotic therapies, and targeted diabetes therapies, are available to reduce this risk in patients with PAD; however, significant residual risk remains. Unfortunately, despite guideline recommendations and efforts at education, even available medical therapies remain underutilized in patients with PAD. Continued development of novel therapies and efforts to improve the provision of care in patients with PAD are needed.

Citing Articles

Association between oxidative balance scores and peripheral artery disease in US adults: a cross-sectional study.

Zhou M, He P, Zhang K, Deng L, Wang N, Wang G Front Nutr. 2025; 11:1497784.

PMID: 39897536 PMC: 11782040. DOI: 10.3389/fnut.2024.1497784.


Acute Pain Management in Peripheral Artery Disease: A Holistic, Beyond-Opioids, Individualized Multimodal Approach.

Ntalouka M, Chatzis A, Nana P, Spanos K, Bareka M, Matsagkas M Turk J Anaesthesiol Reanim. 2024; 52(6):200-206.

PMID: 39679625 PMC: 11650098. DOI: 10.4274/TJAR.2024.241657.


Advancements in textile techniques for cardiovascular tissue replacement and repair.

Bakare A, Ponnambalath Mohanadas H, Tucker N, Ahmed W, Manikandan A, Mohd Faudzi A APL Bioeng. 2024; 8(4):041503.

PMID: 39431050 PMC: 11488978. DOI: 10.1063/5.0231856.


Cost-Effectiveness of Exercise Therapy in Patients with Intermittent Claudication-A Comparison of Supervised Exercise, Home-Based Structured Exercise, and Walk Advice from the SUNFIT Trial.

Ulfsdottir H, Back M, Cider A, Jivegard L, Sandberg A, Nordanstig J J Clin Med. 2023; 12(16).

PMID: 37629318 PMC: 10455939. DOI: 10.3390/jcm12165277.


Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions.

Canonico M, Piccolo R, Avvedimento M, Leone A, Esposito S, Franzone A J Cardiovasc Dev Dis. 2023; 10(4).

PMID: 37103043 PMC: 10144744. DOI: 10.3390/jcdd10040164.

References
1.
Creager M, Pande R, Hiatt W . A randomized trial of iloprost in patients with intermittent claudication. Vasc Med. 2008; 13(1):5-13. DOI: 10.1177/1358863X07084910. View

2.
Freedman B, Berg D, Scirica B, Bohula E, Goodrich E, Sabatine M . Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P-TIMI 50 trial. Clin Cardiol. 2022; 45(8):831-838. PMC: 9346972. DOI: 10.1002/clc.23843. View

3.
Quick C, COTTON L . The measured effect of stopping smoking on intermittent claudication. Br J Surg. 1982; 69 Suppl:S24-6. DOI: 10.1002/bjs.1800691309. View

4.
Benjamin E, Virani S, Callaway C, Chamberlain A, Chang A, Cheng S . Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018; 137(12):e67-e492. DOI: 10.1161/CIR.0000000000000558. View

5.
Gilchrist Jr I, Morrow D, Creager M, Olin J, Scirica B, Goodrich E . Efficacy and Safety of Vorapaxar by Intensity of Background Lipid-Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P-TIMI 50 Trial. J Am Heart Assoc. 2021; 10(20):e021412. PMC: 8751872. DOI: 10.1161/JAHA.121.021412. View